During the 2025 North Carolina Alzheimer’s Advocacy Day, advocates from across the state will gather in Raleigh to discuss two critically important issues with legislators:
- Access to biomarker diagnostic testing for Alzheimer’s
- Increased respite care for dementia caregivers
To learn more about our access to biomarker testing priority, we welcome everyone to join us on Thursday, January 30th at 5:30 – 6:30 p.m. to dive into one of our 2025 state policy priorities and ways to use your voice to support our policy initiatives. Learn about biomarkers, why access matters, and how to use your voice to share this with legislators at the 2025 North Carolina Alzheimer’s Advocacy Day and beyond!
After you RSVP, details for the virtual call will be emailed to you.
210,500 North Carolinians are living with Alzheimer’s, but as many as half of them are not formally diagnosed. An early and accurate diagnosis of dementia can improve access to care and support services, enhance quality of life, and reduce the financial impact of the condition.
Biomarkers (short for “biological markers”) offer one of the most promising paths to improve dementia detection, diagnosis, and treatment. Yet these critical tests remain out of reach for many as insurance coverage is failing to keep pace with innovations and advancements in treatments.
We hope you will join us on this special legislative briefing and learn more about why access to biomarker testing matters.
If you have any questions, please email Lindsey Golden, Director of State Affairs at lagolden@alz.org
Alzheimer's Association North Carolina Blog 